Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study

Biomedicine and Pharmacotherapy

Volumn 65, Issue 2, 2011, Pages 105-110

  Naumovic, Radomir ^a,b   Jovanovic, Dijana ^a,b   Pavlovic, Stevan ^a   Stosovic, Milan ^a   Marinkovic, Jelena ^b   Basta Jovanovic, Gordana ^b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Azathioprine; Cyclosporine; Idiopathic membranous nephropathy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GINGIVA HYPERPLASIA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IDIOPATHIC DISEASE; IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS; LEUKOPENIA; LOW DRUG DOSE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NAUSEA; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AZATHIOPRINE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; PROTEINURIA; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 79954605795     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.10.009     Document Type: Article

References (25)

1. Maisonneuve P., Agodoa L., Gellert R., et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe and Australia/New Zealand: results from and international comparative study. Am J Kidney Dis 2000, 35:157-165.
2. Schieppati A., Mosconi L., Perna A., et al. Prognosi of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993, 329:85-89.
3. Cattran D.C. Idiopathic membranous glomerulonephritis. Kidney Int 2001, 59:1983-1994.
4. Ponticelli C., Zucchelli P., Passerini P., et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995, 48:1600-1604.
5. Torres A., Dominguez-Gil B., Carreno A., et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney Int 2002, 61:219-227.
6. Du Buf-Vereijken P.W.G., Branten A.J.W., Wetzels J.F.M. Cytotoxic therapy for membranous nephropathy and renal insufificiency: improved renal survival but high relapse rate. Nephrol Dial Transplant 2004, 19:1142-1148.
7. Du Buf-Vereijken P.W.G., Wetzels J.F.M. Efficacy of second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity. Nephrol Dial Transplant 2004, 19:2036-2043.
8. Ruggenenti P., Cravedi P., Remuzzi G. Latest treatment strategies for membranous nephropathy. Expert Opin Pharmacother 2007, 8:3159-3171.
9. Cattran D.C., Appel G.B., Hebert L.A., et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 2001, 59:1484-1490.
10. Miller G., Zimmerman R., Radhakrishnan J., Appel G. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 2000, 36:250-256.
11. Alexopoulos E., Papagianni A., Tsamelashvili M., Leontsini M., Memmos D. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 2006, 21:3127-3132.
12. Jayne D., Rasmussen N., Andrassy K., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic antibodies. N Eng J Med 2003, 349:36-44.
13. Perna A., Schieppati A., Zamora J., Giuliano G.A., Braun N., Remuzzi G. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis 2004, 4:385-401.
14. Ahuja M., Goumenos D., Shortland J.R., Gerakis A., Brown C.B. Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?. Am J Kidney Dis 1999, 34:521-529.
15. Brown J.H., Douglas A.F., Murphy B.G., et al. Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone. Nephrol Dial Transplant 1998, 13:443-448.
16. Bone J.M., Rustom R., Williams P.S. Progessive" versus " indolent" idiopathic membraous glomerulonephritis. Q J Med 1997, 90:699-706.
17. Williams P.D., Bone J.M. Immunosuppression can arrest progressive renal failure due to idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 1989, 4:181-186.
18. Goumenos D.S., Ahuja M., Davlouros P., El Nahas A.M., Brown C.B. Prednisolone and ayzathioprine in membranous nephropathy: a 10-year follow-up study. Clin Nephrol 2006, 65:317-323.
19. De Santo N.G., Caposicasa G., Giordano C. Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporine. Am J Nephrol 1987, 7:74-76.
20. Cattran D.C., Greenwood C., Ritchie S., et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 1995, 47:1130-1135.
21. Meyrier A., Noel L.H., Aurishe P., Callard P., the collaborative group of the Société de néphrologie with the tehnical assistance of Broneer D Long-term renal tolerance of cyclosporine A treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994, 45:1446-1456.
22. Fritsche L., Budde K., Farber L., et al. How much patience is requires?. Nephrol Dial Transplant 1999, 14:1036-1037.
23. Goumenos D.S., Kalliakmani P., Tsakas S., Sotsiou F., Vlachojannis J.G. The remission of nephritic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. Clin Nephrol 2004, 61:17-24.
24. Guasch A., Suranyi M., Newton M., Hall B.M., Myers B.D. Short-term responsiveness of membranous glomerulonephropathy to cyclosporine. Am J Kidney Dis 1992, 20:472-481.
25. Goumenos D.S. What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy?. Expert Opin Pharmacother 2008, 9:1695-1704.